SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001728117-23-000081
Filing Date
2023-06-09
Accepted
2023-06-09 16:14:32
Documents
15
Period of Report
2023-06-08
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K goss-20230608.htm   iXBRL 8-K 56800
2 EX-3.1 goss-charteramendmentjun.htm EX-3.1 4364
6 GRAPHIC goss-charteramendmentjun001.jpg GRAPHIC 223513
7 GRAPHIC goss-charteramendmentjun002.jpg GRAPHIC 41462
  Complete submission text file 0001728117-23-000081.txt   571789

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT goss-20230608.xsd EX-101.SCH 1919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT goss-20230608_lab.xml EX-101.LAB 24931
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT goss-20230608_pre.xml EX-101.PRE 13147
9 EXTRACTED XBRL INSTANCE DOCUMENT goss-20230608_htm.xml XML 11643
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

IRS No.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38796 | Film No.: 231005421
SIC: 2834 Pharmaceutical Preparations